Other Mutations: Their Role in Parkinson’s Disease

Parkinson's Disease

Volumn , Issue , 2004, Pages 159-170

  Pankratz, Nathan ^a   Foroud, Tatiana ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745572471     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203508596-25     Document Type: Chapter

References (93)

1. Leroux, P. D., Contribution a l’etude des causes de laparalysie agitante, in These de Paris, 1880. Cited by Scarpalezos, 1948.
2. Scarpalezos, S., Sur la notion d’heredite similaire dans la maladie de Parkinson, Rev Neurol, 80, 184, 1948.
3. Gowers, W. R., A manual of the diseases of the nervous system, 2nd ed., Blakiston, Philadelphia, 636, 1902.
4. Martin, W. E., Young, W. I., and Anderson, V. E., Parkinson’s disease: A genetic study, Brain, 96(3), 495, 1973.
5. Barbeau, A., Roy, M., and Boyer, L., Genetic studies in Parkinson’s disease, Adv. Neurol., 40, 333, 1984.
6. Alonso, M. E. et al., Parkinson’s disease: A genetic study, Can. J. Neurol. Sci., 13(3), 248, 1986.
7. Duvoisin, R. C. and Johnson, W. G., Hereditary Lewybody parkinsonism and evidence for a genetic etiology of Parkinson’s disease, Brain. Pathol., 2(4), 309, 1992.
8. Tanner, C. M. et al., Parkinson’s disease in twins: An etiologic study, JAMA., 281, 341, 1999.
9. Dickson, D. et al., Pathology of PD in monozygotic twins with a 20-year discordance interval, Neurology, 56(7), 981, 2001.
10. Piccini, P. et al., Dopaminergic function in familial Parkinson’s disease: A clinical and 18F-dopa positron emission tomography study, Ann. Neurol., 41(2), 222, 1997.
11. Burn, D. J. et al., Parkinson’s disease in twins studied with 18F-dopa and positron emission tomography, Neurology, 42(10), 1894, 1992.
12. Kuopio, A. et al., Familial occurrence of Parkinson’s disease in a community-based case-control study, Parkinsonism. Relat. Disord., 7(4), 297, 2001.
13. Payami, H. et al., Increased risk of Parkinson’s disease in parents and siblings of patients, Ann. Neurol., 36(4), 659, 1994.
14. Autere, J. M. et al., Familial aggregation of Parkinson’s disease in a Finnish population, J. Neurol. Neurosurg. Psychiatry, 69(1), 107, 2000.
15. Sveinbjornsdottir, S. et al., Familial aggregation of Parkinson’s disease in Iceland, N. Engl. J. Med., 343(24), 1765, 2000.
16. Preux, P. M. et al., Parkinson’s disease and environmental factors: Matched case-control study in the Limousin region, France, Neuroepidemiology, 19(6), 333, 2000.
17. Elbaz, A. et al., Familial aggregation of Parkinson’s disease: A population-based case-control study in Europe; EUROPARKINSON Study Group, Neurology, 52(9), 1876, 1999.
18. Uitti, R. J. et al., Familial Parkinson’s disease: A casecontrol study of families, Can. J. Neurol. Sci., 24(2), 127, 1997.
19. De Michele, G. et al., A genetic study of Parkinson’s disease, J. Neural. Transm. Suppl., 45, 21, 1995.
20. Vieregge, P. et al., (Multifactorial etiology of idiopathic Parkinson disease: A case-control study), Nervenarzt, 65(6), 390, 1994.
21. Polymeropoulos, M. H. et al., Mutation in the alphasynuclein gene identified in families with Parkinson’s disease, Science, 276(5321), 2045, 1997.
22. Bostantjopoulou, S. et al., Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation, Mov. Disord., 16(6), 1007, 2001.
23. Gasser, T., Genetics of Parkinson’s disease, J. Neurol., 248(10), 833, 2001.
24. Kruger, R. et al., Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease, Nat. Genet., 18(2), 106, 1998.
25. Farrer, M. et al., Low frequency of alpha-synuclein mutations in familial Parkinson’s disease, Ann. Neurol., 43(3), 394, 1998.
26. Singleton, A. et al., SNCA locus triplication causes Parkinson disease, Science, in press
27. Pastor, P. et al., Analysis of the coding and the 5’ flanking regions of the alpha-synuclein gene in patients with Parkinson’s disease, Mov. Disord., 16(6), 1115, 2001
28. Chan, P. et al., Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson’s disease, Neurology, 50(4), 1136, 1998.
29. Farrer, M. et al., Low frequency of alpha-synuclein mutations in familial Parkinson’s disease, Ann. Neurol., 43(3), 394, 1998.
30. Vaughan, J. R. et al., Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson’s disease fails to reveal any further mutations; The European Consortium on Genetic Susceptibility in Parkinson’s Disease (GSPD), Hum. Mol. Genet., 7(4), 751, 1998.
31. Leroy, E. et al., The ubiquitin pathway in Parkinson’s disease, Nature, 395(6701), 451, 1998.
32. Wintermeyer, P. et al., Mutation analysis and association studies of the UCHL1 gene in German Parkinson’s disease patients, Neuroreport., 11(10), 2079, 2000.
33. Pickart, C. M., Ubiquitin in chains, Trends. Biochem. Sci., 25(11), 544, 2000.
34. Chung, K. K. et al., Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease. Nat. Med., 7(10), 1144, 2001.
35. Pankratz, N. et al., Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations, Am. J. Hum. Genet., 71(1), 124, 2002.
36. Scott, W. K. et al., Complete genomic screen in Parkinson disease: Evidence for multiple genes, JAMA, 286(18), 2239, 2001.
37. Hicks, A. A. et al., A susceptibility gene for late-onset idiopathic Parkinson’s disease, Ann. Neurol., 52(5), 549, 2002.
38. Marx, F. P. et al., Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson’s disease. Hum. Mol. Genet., 12(11), 1223, 2003.
39. Gasser, T. et al., A susceptibility locus for Parkinson’s disease maps to chromosome 2p13, Nat. Genet., 18, 262, 1998.
40. Funayama, M. et al., A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2-q13.1, Ann. Neurol., 51(3), 296, 2002.
41. Yamamura, Y. et al., Paralysis agitans of early-onset with marked diurnal fluctuation of symptoms, Neurology, 23, 239, 1973.
42. Ishikawa, A. and Tsuji, S., Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile Parkinsonism, Neurology, 47, 160, 1996.
43. Kitada, T. et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 1998.
44. Lucking, C. B. et al., Association between early-onset Parkinson’s disease and mutations in the parkin gene; French Parkinson’s Disease Genetics Study Group, N. Engl. J. Med., 342(21), 1560, 2000.
45. Foroud, T. et al., Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease, Neurology, 60(5), 796, 2003.
46. Oliveira, S. A. et al., Parkin mutations and susceptibility alleles in late-onset Parkinson’s disease, Ann. Neurol., 53(5), 624, 2003.
47. Tan, L. C. et al., Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation, Mov. Disord., 18(7), 758, 2003.
48. Nichols, W. C. et al., Linkage stratification and mutation analysis at the parkin locus identifies mutation positive, Parkinson disease families, J. Med. Genet., 39, 489, 2002.
49. Kann, M. et al., Role of parkin mutations in 111 community-based patients with early-onset parkinsonism, Ann. Neurol., 51(5), 621, 2002.
50. West, A. et al., Complex relationship between Parkin mutations and Parkinson disease, Am. J. Med. Genet., 114(5), 584, 2002.
51. Hedrich, K. et al., Evaluation of 50 probands with earlyonset Parkinson’s disease for Parkin mutations, Neurology, 58(8), 1239, 2002.
52. Lucking, C. B. et al., Association between early-onset Parkinson’s disease and mutations in the parkin gene; French Parkinson’s Disease Genetics Study Group, N. Engl. J. Med., 342(21), 1560, 2000.
53. Abbas, N. et al., A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe; French Parkinson’s Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson’s Disease, Hum. Mol. Genet., 8(4), 567, 1999.
54. Lucking, C. B. et al., Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism; The European Consortium on Genetic Susceptibility in Parkinson’s Disease and the French Parkinson’s Disease Genetics Study Group, Lancet, 352(9137), 1355, 1998.
55. Klein, C. et al., Parkin deletions in a family with adultonset, tremor-dominant parkinsonism: Expanding the phenotype, Ann. Neurol., 48(1), 65, 2000.
56. Farrer, M. et al., Lewy bodies and parkinsonism in families with parkin mutations, Ann. Neurol., 50(3), 293, 2001.
57. Valente, E. M. et al., Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on chromosome 1p35-p36, Am. J. Hum. Genet., 68, 895, 2001.
58. Valente, E. M. et al., PARK6-linked parkinsonism occurs in several European families, Ann. Neurol., 51(1), 14, 2002.
59. van Duijn, C. M. et al., PARK7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36, Am. J. Hum. Genet., 69, 629, 2001.
60. Nagakubo, D. et al., DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras, Biochem. Biophys. Res. Commun., 231(2), 509, 1997.
61. Wagenfeld, A., Gromoll, J., and Cooper, T.G., Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization, Biochem. Biophys. Res. Commun., 251(2), 545, 1998.
62. Okada, M. et al., DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice, Biol. Pharm. Bull., 25(7), 853, 2002.
63. Mitsumoto, A. and Nakagawa, Y., DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin, Free. Radic. Res., 35(6), 885, 2001.
64. Bonifati, V. et al., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism, Science, 299(5604), 256, 2003.
65. Pankratz, N. et al., Genome-Wide Linkage Analysis and Evidence of Gene-by-Gene Interactions in a Sample of 362 Multiplex Parkinson Disease Families, Hum. Mol. Genet., in press.
66. Pankratz, N. et al., Significant linkage of Parkinson disease to chromosome 2q36-37, Am. J. Hum. Genet., 72(4), 1053, 2003.
67. DeStefano, A.L. et al., Genome-wide scan for Parkinson’s disease: The GenePD Study, Neurology, 57(6), 1124, 2001.
68. Lee, L. V. et al., Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP), Mol. Pathol., 54(6), 362, 2001.
69. Nemeth, A. H. et al., Refined linkage disequilibrium and physical mapping of the gene locus for X-linked dystonia-parkinsonism (DYT3), Genomics., 60(3), 320, 1999.
70. Rioux, J. D. et al., Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease, Nat. Genet., 29, 223, 2001.
71. Daly, M. J. et al., High-resolution haplotype structure in the human genome, Nat. Genet., 29, 229, 2001.
72. Johnson, G. C. et al., Haplotype tagging for the identification of common disease genes, Nat. Genet., 29, 233, 2001.
73. Patil, N. et al., Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21, Science, 294, 1719, 2001.
74. Gabriel, S. B. et al., The structure of haplotype blocks in the human genome, Science, 296, 2225, 2002.
75. Spielman, R. S., McGinnis, R. E., and Ewens, W. J., Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM), Am. J. Hum. Genet., 52(3), 506, 1993.
76. Martin, E. R. et al., A test for linkage and association in general pedigrees: The pedigree disequilibrium test, Am. J. Hum. Genet., 67(1), 146, 2000.
77. Boehnke, M. and Langefeld, C. D., Genetic association mapping based on discordant sib pairs: The discordantalleles test, Am. J. Hum. Genet., 62(4), 950, 1998.
78. Horvath, S. and Laird, N. M., A discordant-sibship test for disequilibrium and linkage: No need for parental data, Am. J. Hum. Genet., 63(6), 1886, 1998.
79. Curtis, D., Use of siblings as controls in case-control association studies, Ann. Hum. Genet., 61 (Pt. 4), 319, 1997.
80. Mellick, G. D. et al., Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson’s disease, Mov. Disord., 14(2), 219, 1999.
81. Grevle, L. et al., Allelic association between the DRD2 TaqI A polymorphism and Parkinson’s disease, Mov. Disord., 15(6), 1070, 2000.
82. Nicholl, D. J. et al., A study of five candidate genes in Parkinson’s disease and related neurodegenerative disorders; European Study Group on Atypical Parkinsonism, Neurology, 53(7), 1415, 1999.
83. Spielman, R. S. and Ewens, W. J., The TDT and other family-based tests for linkage disequilibrium and association, Am. J. Hum. Genet., 59(5), 983, 1996.
84. Xu, P. Y. et al., Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson’s disease, Neurology, 58(6), 881, 2002.
85. Zheng, K., Heydari, B., and Simon, D. K., A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease, Arch. Neurol., 60(5), 722, 2003.
86. Le, W. D. et al., Mutations in NR4A2 associated with familial Parkinson disease, Nat. Genet., 33(1), 85, 2003.
87. van der Walt, J. M. et al., Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease, Am. J. Hum. Genet., 72(4), 804, 2003.
88. Seidler, A. et al., Possible environmental, occupational, and other etiologic factors for Parkinson’s disease: A case-control study in Germany, Neurology, 46(5), 1275, 1996.
89. Koller, W. et al., Environmental risk factors in Parkinson’s disease, Neurology., 40(8), 1218, 1990.
90. Louis, E. D. et al., Parkinsonian signs in older people: Prevalence and associations with smoking and coffee, Neurology, 61(1), 24, 2003.
91. Ross, G. W. et al., Association of coffee and caffeine intake with the risk of Parkinson disease, JAMA, 283(20), 2674, 2000.
92. Zarranz, J. J. et al., The new mutation, E46K, of alphasynuclein causes Parkinson and Lewy body dementia, Ann. Neurol., 55(2), 164, 2004.
93. Valente, E. M. et al., Hereditary early-onset Parkinson’s disease caused by mutations in PINK1, Science, 304(5674), 1158, 2004.